+6,351.7%
AMD vs GSK
+103.4%
+6,248.4%
-65.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +11.0% | -0.2% | +11.2% | +11.1% |
| 7D | -11.0% | +1.7% | -12.7% | -11.3% |
| 30D | -30.5% | +7.0% | -37.5% | -31.7% |
| 3M | -8.2% | -2.7% | -5.6% | -8.0% |
| 6M | +6.6% | +1.4% | +5.1% | +4.9% |
| YTD | +109.7% | +5.3% | +104.3% | +101.4% |
| 1Y | +88.9% | +10.6% | +78.3% | +78.2% |
| 3Y | +301.8% | +62.6% | +239.2% | +214.1% |
| 5Y | +229.4% | +41.7% | +187.7% | +168.2% |
| All | +6,351.7% | +103.4% | +6,248.4% | +4,511.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling